首页> 外文期刊>Mayo Clinic Proceedings >Medication errors in patients with severe chronic kidney disease and acute coronary syndrome: The impact of computer-assisted decision support
【24h】

Medication errors in patients with severe chronic kidney disease and acute coronary syndrome: The impact of computer-assisted decision support

机译:重症慢性肾脏病和急性冠状动脉综合征患者的用药错误:计算机辅助决策支持的影响

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate the impact of computerized physician order entry (CPOE) with decision support on the frequency of antithrombotic medication errors in patients with chronic kidney disease (CKD) admitted with acute coronary syndrome (ACS) and to measure what effect it would have on in-hospital bleeding. PATIENTS AND METHODS: We evaluated 80 patients with CKD who were admitted with ACS between January 1, 2009, and December 31, 2010, using either a standardized order set or CPOE with decision support to assess the frequency of medication errors and in-hospital bleeding. RESULTS: Of the 80 patients, 47 were admitted with standard orders vs 33 with CPOE. In-hospital bleeding occurred in 13 patients: 10 in the standard orders group vs 3 in the CPOE group (p=.12). In-hospital bleeding occurred in 5 (63%) of 8 patients receiving a contraindicated antithrombotic medication compared with 8 (11%) of 72 patients receiving appropriate medications (p=.002); the corresponding length of stay was 12.0 days compared with 6.8 days (p=.10). Contrain-dicated medications were given to no patients in the CPOE group vs 8 patients (17%) in the standard orders group (p=.01). CONCLUSION: Medication errors occur frequently in patients with CKD admitted with ACS and result in a high risk of in-hospital bleeding. Use of CPOE with decision support is feasible in the ACS setting and may lead to improved patient safety.
机译:目的:评估计算机化医师订单输入(CPOE)和决策支持对急性冠脉综合征(ACS)所收治的慢性肾脏病(CKD)患者抗血栓药物错误发生频率的影响,并评估其对治疗的影响院内出血。病人和方法:我们使用标准化的订单集或带有决策支持的CPOE评估了2009年1月1日至2010年12月31日之间ACS入院的80例CKD患者,以评估用药错误和院内出血的频率。结果:在80例患者中,有47例接受标准治疗,而33例接受CPOE治疗。 13例患者发生院内出血:标准订单组10例,而CPOE组3例(p = .12)。接受禁忌抗凝药物治疗的8名患者中有5名(63%)发生院内出血,而接受适当药物治疗的72名患者中有8名(11%)发生(p = .002);相应的住院时间为12.0天,而同期为6.8天(p = .10)。 CPOE组中没有患者使用禁忌药物,而标准订单组中8个患者(17%)没有服用禁忌药物(p = .01)。结论:ACS导致的CKD患者经常发生用药错误,导致院内出血的高风险。在ACS设置中,将CPOE与决策支持一起使用是可行的,并且可以提高患者的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号